Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI.

Medicine (Baltimore) · 2018 · PMC6393082 · PMID 29718868

Europe PMC DOI

hedged sentence

0.1700

closest p · 3.4× alpha

0.1700

boldest claim

The sentences

an overall trendP = .17not close (p > 0.1)

2 , although there was an overall trend in favor of iodixanol, no significant difference was found in the risk of CIN between the iodixanol and iopromide group (OR 0.50, 95% CI 0.19–1.35, P = .17).

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.